ÂÜÀòÂÒÂ×

Dr. Gutheil is a board-certified Medical Oncologist with more than 35 years devoted to oncology clinical research. He previously served as CEO and CMO of Proacta, Inc., VP of Medical Affairs for Favrille, Inc., Executive Director of Clinical Research and Development at Vical, Inc. Prior to his career in biotech, Dr. Gutheil was the Director of Clinical Research at the Sidney Kimmel Cancer Center in San Diego and an attending physician at the University of Maryland Cancer Center in Baltimore, where he was Co-director of the Neuro-oncology Program and Director of the Fellowship Program, the Community Physician Outreach Program and the Outpatient Clinic. During his time at the University of Maryland, Dr. Gutheil was the recipient of a physician-scientist NCI T-32 award.

Dr. Gutheil received a BS in Biology from the University of California, San Diego and his MD from the Medical College of Wisconsin. He completed an internal medicine residency at Johns Hopkins University and a Medical Oncology fellowship at the University of Maryland Cancer Center.